EURE_CART header image
EURE_CART header image
EURE_CART header image
Ospedale Pediatrico Bambin Gesù

OPBG is a Scientific Institute for Research and Health Care, Italy’s main paediatric Hospital providing advanced health care for children and performing basic, clinical and translational research activities. The Hospital is part of the Italian National Healthcare System and is widely recognized as referral centre for all paediatrics specialties at national and international levels. The Hospital offers a complete range of healthcare services to children.

 

OPBG has a total permanent staff of approximately 2.500 employees, of which 550 physicians, 45 biologists and pharmacists, involved both in clinical and in research activities. The Hospital’s clinical activities run side by side with its scientific research, aiming at constantly improving and innovating diagnostic and therapeutic procedures.

 

The Department of Pediatric Onco-haematology and Transfusion Medicine, chaired by Prof. Franco Locatelli, is the main Italian Centre for the care and research in the field of paediatric Haematology and Oncology, and is internationally known as a centre of excellence. In the last years, the Department was given a further boost by the development of the programme for the transplantation of haemopoietic stem cells from partially HLA-compatible family donor (haploidentical transplant) for patients suffering from haematological disorders. The Department plays an active part in the experimental activities and protocols managed under the aegis of the ITCC (Innovative Treatment for Children with Cancer) European Participant, promoting and coordinating numerous phase I, phase II and phase III studies on the use of new drugs in paediatric oncohaematological diseases.

 

Around 1/8 of the whole number of new diagnoses of cancer in pediatic patients in Italy are performed at the Department of Haematology/Oncology of the Bambino Gesù Hospital, which coordinates the National protocols for childhood AML, as well as of infant -leukaemia and relapsed acute lymphoblastic leukaemia. This centre is credited as one of the most qualified worldwide in paediatric HSCT and adoptive immunotherapy for the prevention and treatment of both leukaemia relapse and infectious complications occurring in immunocompromised individuals. In the Bambino Gesù Hospital, all types of allograft (i.e. cord blood transplants, T cell depleted transplants from HLA-partially matched relatives, matched unrelated donor transplants) are routinely employed for treating children with either malignant or non-malignant disorders.

Roles and tasks of OPBG in EURE-CART

OPBG will lead WP5 “Follow-up of EURE-CART Phase I/IIa and correlative studies”  as responsible for correlative studies in patients treated with EURE-CART  and it contribute to WP3, WP4, WP6  and to the dissemination activities.

EURE-CART team at OPBG

Prof. Franco Locatelli
Director - Department of Pediatric Oncohaematology and Transfusion Medicine

PhD Concetta Quintarelli
Head of Laboratory of Cell and Gene Therapy for Pediatric Tumors

PhD Ignazio Caruana
Research Assistant at the Department of Pediatric Oncohaematology and Transfusion Medicine

MD Daria Pagliara
Pediatrician at the Department of Pediatric Oncohaematology and Transfusion Medicine
Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

The members of the EURECART´s Consortium gather in Lisbon for the 2nd General... Read more